Skip to main content
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.980
-0.080 (-1.97%)
At close: Nov 13, 2026, 4:00 PM EST
4.095
+0.115 (2.89%)
After-hours: Nov 13, 2026, 5:59 PM EST

Opus Genetics Revenue

Opus Genetics had revenue of $1.14M in the quarter ending September 30, 2026, a decrease of -63.07%. This brings the company's total for the last twelve months to $7.91M, down -45.92% year-over-year. In the year 2025, Opus Genetics had annual revenue of $14.20M with 29.15% growth. That makes Opus Genetics the 38,374th largest company in the world by revenue and 5,035th in the United States.

Revenue (ttm)
$7.91M
Revenue Growth
-45.92%
P/S Ratio
48.61
Revenue / Employee
$282,643
Employees
28
Market Cap
384.68M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.20M3.20M29.15%
Dec 31, 202410.99M-8.06M-42.30%
Dec 31, 202319.05M-20.80M-52.20%
Dec 31, 202239.85M39.26M6,665.70%
Dec 31, 2021589.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 200875.00K--
Dec 31, 200775.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CorMedix412.49M
ARS Pharmaceuticals122.14M
Assembly Biosciences67.01M
Fennec Pharmaceuticals66.37M
Lyell Immunopharma15.00K
Revenue Rankings

IRD News

More News